George C Wood Selected Research

George C Wood Research Topics

6	Neoplasms (Cancer) 04/2018 - 07/2005
2	Edema (Dropsy) 03/2018 - 01/2016
2	Inflammation (Inflammations) 03/2018 - 01/2016
1	Mycoses (Diseases, Fungus) 03/2020
1	Cardiotoxicity 04/2018
1	Acute Lung Injury 03/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Adenocarcinoma of Lung 01/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Myocardial Infarction 03/2007
1	Melanoma (Melanoma, Malignant) 07/2005

5	Liposomes (Liposome)IBA 03/2018 - 07/2005
3	Peptides (Polypeptides)IBA 03/2018 - 04/2006
2	Interleukin-1beta (Interleukin 1 beta)IBA 03/2018 - 01/2016
2	IntegrinsIBA 01/2016 - 07/2005
2	PolymersIBA 01/2016 - 11/2010
1	Nanoparticle Drug Delivery SystemIBA 03/2020
1	Amphotericin B (Amphotericin)FDA LinkGeneric 03/2020
1	N-benzyladriamycin-14-valerate (AD 198)IBA 04/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2018
1	AnthracyclinesIBA 04/2018
1	Arginine (L-Arginine)FDA Link 03/2018
1	D-Aspartic Acid (D Aspartate)IBA 03/2018
1	Biomarkers (Surrogate Marker)IBA 03/2018
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 03/2018
1	CytokinesIBA 01/2016
1	LipidsIBA 01/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016
1	ChemokinesIBA 01/2016
1	VaccinesIBA 05/2013
1	Biocompatible Materials (Biomaterials)IBA 11/2010
1	Drug CarriersIBA 03/2007
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 05/2006
1	aspartic acid glycine arginineIBA 05/2006
1	arginyl-glycyl-aspartic acidIBA 04/2006
1	cyclic arginine-glycine-aspartic acid peptideIBA 04/2006
1	fosbretabulin (combretastatin A4)IBA 04/2006
1	combretastatinIBA 07/2005

1	Drug Therapy (Chemotherapy) 05/2013
1	Therapeutics 05/2013